cimadronate has been researched along with Bone Neoplasms in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asahi, H; Komatsu, K; Koshida, K; Maeda, Y; Mizokami, A; Namiki, M | 1 |
Futakuchi, M; Hikosaka, A; Kohri, K; Ogiso, T; Shirai, T; Suzuki, S | 1 |
Kubo, T; Matsuo, T; Ochi, M; Sakai, A; Shimose, S; Tanaka, K; Yasunaga, Y | 1 |
Fujii, Y; Fukui, I; Kijima, T; Okubo, Y; Suyama, T; Yonese, J | 1 |
Koizumi, M; Ogata, E | 1 |
Hiraga, T; Nakajima, T; Ozawa, H; Tanaka, S; Yamamoto, M | 1 |
Higuchi, S; Nakamura, E; Ozawa, Y; Sonoda, T; Tanaka, S; Teramura, K; Usui, T; Watanabe, T | 1 |
Kokawa, Y; Naito, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G | 1 |
Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
Iwao, H; Ochi, H; Shigematsu, M; Shomi, S | 1 |
10 other study(ies) available for cimadronate and Bone Neoplasms
Article | Year |
---|---|
Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Bone Neoplasms; Diphosphonates; Drug Resistance, Neoplasm; Drug Therapy, Combination; Estramustine; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms | 2003 |
Lack of prophylactic effect of incadronate on skeletal lesions associated with implants of prostate cancer.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Male; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred F344; Treatment Failure | 2006 |
Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Sarcoma; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2006 |
Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Pamidronate; Zoledronic Acid | 2008 |
Bisphosphonate effect on bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Diphosphonates; Humans; Radionuclide Imaging | 1996 |
Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumor.
Topics: Acid Phosphatase; Animals; Biomarkers, Tumor; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Immunohistochemistry; Isoenzymes; Male; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Tartrate-Resistant Acid Phosphatase; Tumor Cells, Cultured | 1996 |
Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastases.
Topics: Animals; Autoradiography; Bone Neoplasms; Cell Division; Diphosphonates; Half-Life; Male; Melanoma, Experimental; Metabolic Clearance Rate; Neoplasm Transplantation; Rats; Rats, Nude | 1997 |
[Study on the safety of rapid infusion and the efficacy of incadronate against bone metastasis of breast cancer].
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged | 1999 |
[A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pamidronate | 2000 |
New bone-seeking agent: animal study of Tc-99m-incadronate.
Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Feasibility Studies; Female; Hydrogen-Ion Concentration; Kidney; Models, Molecular; Muscles; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Tissue Distribution; Urine; Whole-Body Counting | 2002 |